Président du comité d’éthique de l’Inserm
Directeur de recherche CNRS
01 40 78 92 01
Copyright : Pierre Malaval
Hervé Chneiweiss, medical doctor and scientist, neurologist and neurobiologist, has always integrated the ethical questions posed by progress and research into his clinical and scientific work. From 2000 to 2002, he was a technical consultant for life sciences and bioethics at the Ministry of Research. He has been a member of the Inserm Ethics Committee since 2003 and has contributed to numerous articles published in international scientific reviews and works on bioethics.
He will be President of the Ethics Committee, whose work is to discuss and develop reflection on ethical aspects of practices used for biomedical research; to keep watch and advise in order to prepare the conditions for innovatory research and ensure that all practices are accompanied by ethical principles, particularly as concerns their impacts and consequences; to ensure awareness and guidance in ethical questions and to play a full part in communication between the scientific and medical community, Inserm and Society.
Hervé Chneiweiss is delighted with this
Hervé Chneiweiss is also Research Director of the “Glial plasticity and brain tumors” research team and is Director of the Paris-Seine Neurosciences Laboratory (Inserm/CNRS/UPMC) at the new Paris-Seine Institute of Biology, that groups together the biology laboratories from the Jussieu campus.
He is working on the biology of a specific population of cells from the nervous system, known as astrocytes. Astrocytes make up half of all brain cells and fulfill numerous functions, from constructing the architecture of the brain to being involved in each phase of communication between neurons. Hervé’s team are making a specific study into the mechanisms that link astyrocytes to the cause and development of brain tumors. By characterizing stem cells within brain tumors, it could be possible to develop new therapeutic strategies to fight cancer.
Editor of the review Médecine/Sciences since 2006, Hervé Chneiweiss is also a member of the Scientific Council of the Parliamentary Office of Scientific and Technological Assessment (OPECST), member of the Scientific Council of the French Foundation for Medical Research (FRM) and of the Institute of Biological Sciences at the CNRS.
He is also co-author of “Bioéthique: Avis de tempêtes” (with Jean-Yves Nau, Alvik, 2003), and author of “Neuroscience et Neuroéthique : des cerveaux libres et heureux” (Alvik 2006) and “L’homme réparé” (Plon 2012).
Cyril Schiever, Chairman of the Board of MSDAVENIR, Professor Yves Lévy, Chairman and CEO of Inserm and Pascale Augé, President of the Executive Board of Inserm Transfert, today signed a strategic framework agreement to support French medical research.This event took place under ...
The European Patents Office (EPO) has just published its annual rankings: For the first time, Inserm has taken the top ranking for applicants in the pharmaceutical sector ahead of the big industrial companies and can confirm at the same time its top ...